Skip to main content

Corona Virus Disease

2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Marius Pharmaceuticals
1 program
1
RoActemra ivPhase 21 trial
Active Trials
NCT04322773Terminated20Est. Oct 2020
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
1
AZD7442Phase 11 trial
Active Trials
NCT05166421Completed224Est. Jul 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Marius PharmaceuticalsRoActemra iv
AstraZenecaAZD7442

Clinical Trials (2)

Total enrollment: 244 patients across 2 trials

Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure

Start: Apr 2020Est. completion: Oct 202020 patients
Phase 2Terminated

Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy Participants

Start: Nov 2021Est. completion: Jul 2023224 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.